Methotrexate is prescribed to at least 500,000 patients with rheumatoid arthritis (RA) worldwide; the best route of administration, however, is not clear. This multicenter, phase IV, randomized, ...

Twenty doses of outpatient HD-MTX with glucarpidase were administered to seven patients. After 20 of 20 (100%) treatments, serum MTX levels were reduced to <100 nmol/L. Treatments were well-tolerated, ...

Two other potentially important questions not addressed in this analysis are the effect of the cell dose 5 and the effect of the administration of myeloid growth factors early after transplantation. 6 ...

Methotrexate 1g/vial; pwd for IV, IM, intra-arterial, or intrathecal administration after dilution; preservative-free. Non-metastatic osteosarcoma in patients who have undergone surgical resection or ...

Please provide your email address to receive an email when new articles are posted on . Subcutaneous methotrexate is safe in clinical practice, and is continued longer and better tolerated than other ...

Methotrexate is a primary disease-modifying anti-rheumatic drug (DMARD) used to treat rheumatoid arthritis (RA) by reducing inflammation and suppressing the immune system. The American College of ...

Surrey, UK - A review on the use of folate as a supplement to methotrexate therapy in rheumatoid arthritis (RA) has prompted at least 1 UK doctor to change his prescribing habits. In their review, ...

Methotrexate injection device approved The FDA has approved Otrexup for adults with active, severe rheumatoid arthritis or psoriasis who haven't responded first line therapy and children with active ...